This publication treats that phrase as brand positioning - not a verified physiological claim
La principal diferencia es que el esquema de dosificacin se establece de forma distinta segn el uso previsto: Wegovy tiene una dosis de mantenimiento ms alta, ya que es ms adecuada para el control del peso
Patients administer a weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm
Common adverse effects of GLP-1 receptor agonists include nausea, vomiting, diarrhoea, and constipation, which occur in a significant proportion of patients, particularly during dose escalation
Wegovy contains semaglutide, a medicine that acts like the natural hormone GLP-1
Other Important Safety Information Semaglutide has other potential risks that should be taken into account